<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Melanoma Research Foundation | DBOdom | Activity</title>
	<link>https://forum.melanoma.org/user/dbodom/activity/</link>
	<atom:link href="https://forum.melanoma.org/user/dbodom/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for DBOdom.</description>
	<lastBuildDate>Wed, 22 Apr 2026 22:54:37 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4afd0774b24ea9cb2ae140a5235b344c</guid>
				<title>DBOdom replied to the topic HyperAcute Melanoma Vaccine with PEG-Intron in the forum General Melanoma Community</title>
				<link>https://forum.melanoma.org/forums/topic/hyperacute-melanoma-vaccine-with-peg-intron/#post-276598</link>
				<pubDate>Wed, 13 Apr 2022 18:56:39 -0400</pubDate>

									<content:encoded><![CDATA[<p>Updated link for trial results: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052581/" rel="nofollow ugc">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052581/</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6d593662ac584bf6b5ebe109f4158c7a</guid>
				<title>DBOdom&#039;s profile was updated</title>
				<link>https://forum.melanoma.org/activity/p/17033/</link>
				<pubDate>Wed, 13 Apr 2022 18:49:55 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2f0e02b4588a7bf2a6e040587b70fe16</guid>
				<title>DBOdom&#039;s profile was updated</title>
				<link>https://forum.melanoma.org/activity/p/4094/</link>
				<pubDate>Thu, 27 May 2021 02:24:32 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>